Embryonic stem cell potency fluctuates with endogenous retrovirus activity

Macfarlan, Todd S.; Gifford, Wesley D.; Driscoll, Shawn; Lettieri, Karen; Rowe, Helen M.; Bonanomi, Dario; Firth, Amy; Singer, Oded; Trono, Didier; Pfaff, Samuel L.
July 2012
Nature;7/5/2012, Vol. 487 Issue 7405, p57
Academic Journal
Embryonic stem (ES) cells are derived from blastocyst-stage embryos and are thought to be functionally equivalent to the inner cell mass, which lacks the ability to produce all extraembryonic tissues. Here we identify a rare transient cell population within mouse ES and induced pluripotent stem (iPS) cell cultures that expresses high levels of transcripts found in two-cell (2C) embryos in which the blastomeres are totipotent. We genetically tagged these 2C-like ES cells and show that they lack the inner cell mass pluripotency proteins Oct4 (also known as Pou5f1), Sox2 and Nanog, and have acquired the ability to contribute to both embryonic and extraembryonic tissues. We show that nearly all ES cells cycle in and out of this privileged state, which is partially controlled by histone-modifying enzymes. Transcriptome sequencing and bioinformatic analyses showed that many 2C transcripts are initiated from long terminal repeats derived from endogenous retroviruses, suggesting this foreign sequence has helped to drive cell-fate regulation in placental mammals.


Related Articles

  • Transposable elements: ERE and there for pluripotency. Burgess, Darren J. // Nature Reviews Genetics;Jul2017, Vol. 15 Issue 7, p439 

    The article focuses on the study in Professor Didier Trono's laboratory in Switzerland on the mechanisms of endogenous retroelements (EREs) in human embryonic stem cells (ESCs) and its implication for the use of induced pluripotent stem cells (iPSCs). Topics discussed include the role of EREs in...

  • Program and Abstracts of the 12th Transgenic Technology Meeting (TT2014).  // Transgenic Research;Oct2014, Vol. 23 Issue 5, p827 

    The article presents abstracts on transgenic technology which include the research in induced pluripotent stem (iPS) cell technology and gene editing, in-vivo validation of cancer genes and drug targets, and embryonic stem cells.

  • Antibody-Directed Lentiviral Gene Transduction for Live-Cell Monitoring and Selection of Human iPS and hES Cells. Dai-tze Wu; Seita, Yasunari; Xia Zhang; Chi-Wei Lu; Roth, Monica J. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    The identification of stem cells within a mixed population of cells is a major hurdle for stem cell biology-in particular, in the identification of induced pluripotent stem (iPS) cells during the reprogramming process. Based on the selective expression of stem cell surface markers, a method to...

  • THE CHANGING FACE OF THERAPEUTICS: AN INTRODUCTION TO STEM CELL AND REGENERATIVE THERAPIES. Seewoodhary, Jason // West London Medical Journal;Sep2011, Vol. 3 Issue 3, p28 

    Stem cell therapies are revolutionizing therapeutics by providing a curative approach to diseases for which, until very recently, symptomatic treatments were only available. This review will critically consider the multidisciplinary role, use and implications of embryonic, adult, and induced...

  • Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Wang, Fang; Yin, Yu; Ye, Xiaoying; Liu, Kai; Zhu, Haiying; Wang, Lingling; Chiourea, Maria; Okuka, Maja; Ji, Guangzhen; Dan, Jiameng; Zuo, Bingfeng; Li, Minshu; Zhang, Qian; Liu, Na; Chen, Lingyi; Pan, Xinghua; Gagos, Sarantis; Keefe, David L; Liu, Lin // Cell Research;Apr2012, Vol. 22 Issue 4, p757 

    Rejuvenation of telomeres with various lengths has been found in induced pluripotent stem cells (iPSCs). Mechanisms of telomere length regulation during induction and proliferation of iPSCs remain elusive. We show that telomere dynamics are variable in mouse iPSCs during reprogramming and...

  • Data Questioned: No Immune Response to iPSCs After All? Breindl, Anette // BioWorld Today;1/14/2013, Vol. 24 Issue 9, p11 

    The article reports on the challenge of the Japanese National Institute of Radiological Sciences' researchers regarding the findings that induced pluripotent stem cells (iPSCs) may result to immune rejection. It states that iPSCs could elicit an immune response due of being genetically unstable....

  • Adult Stem Cell Treatments Move Ahead, Embryonic Stem Cells Fall Farther Behind. Prentice, David A. // National Right to Life News;Summer2012, Vol. 39 Issue 3, p14 

    The article highlights induced pluripotent stem (iPS) cell treatment as a more effective and ethically viable method than embryonic stem cell treatment. It explains that iPS cells are made by adding a few genes to an adult cell, which allows it to act like an embryonic stem cell, removing the...

  • Endodermal and Hepatic Differentiation from Human Embryonic Stem Cells and Human Induced Pluripotent Stem Cells. Kawabata, Kenji; Takayama, Kazuo; Nagamoto, Yasuto; Saldon, Mary S.; Higuchi, Maiko; Mizuguchi, Hiroyuki // Journal of Stem Cell Research & Therapy;Special2012, Vol. 2 Issue S, Special section p1 

    Induced hepatocytes differentiated from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) have a wide range of potential applications in biomedical research, drug discovery, and the treatment of liver disease. Differentiation of human ESCs and iPSCs into endodermal and...

  • Stem cells and regenerative medicine -- future perspectives. Brunt, Keith R.; Weisel, Richard D.; Ren-Ke Li // Canadian Journal of Physiology & Pharmacology;Mar2012, Vol. 90 Issue 3, p327 

    Stem cell research has expanded at an exponential rate, but its therapeutic applications have progressed much more slowly. Currently, the research focuses on understanding embryonic, adult, and inducible pluripotent stem cells. Translation of adult stem cell research has established a definitive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics